This was bolstered by findings that increasing TCF4 expression in PTHS patient-derived brain organoids could overcome deficits in electrophysiological, cytoarchitectural, and transcriptional dysregulation phenotypes (Papes et al., 2022). Here, TCF4 is linked to Pitt-Hopkins syndrome.